Model for end-stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia

被引：15
|
作者：
Garcia-Tsao, Guadalupe
Gish, Robert G.
Punch, Jeffrey
机构：
[1] Calif Pacific Med Ctr, Dept Med, San Francisco, CA 94115 USA
[2] Calif Pacific Med Ctr, Dept Transplantat, San Francisco, CA 94115 USA
[3] Calif Pacific Med Ctr, Div Hepatol & Complex Gastroenterol, Phys Fdn, San Francisco, CA 94115 USA
[4] Yale Univ, Sch Med, New Haven, CT USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
LIVER TRANSPLANTATION | 2006年 / 12卷 / 12期
关键词：
D O I：
10.1002/lt.20978
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S108 / S109
页数：2
相关论文
共 50 条
  • [41] Model for End-Stage Liver Disease (MELD) predicts survival in patients with variceal bleeding
    Bambha, KM
    Van Ijperen, M
    Malinchoc, M
    Kremers, WK
    Kim, RW
    Wiesner, RH
    Kamath, PS
    GASTROENTEROLOGY, 2003, 124 (04) : A665 - A665
  • [42] Model for End-Stage Liver Disease (MELD) predicts survival in patients with variceal bleeding
    van Ijperen, M
    Bambha, KM
    Malinchoc, M
    Kremers, WK
    Kim, WR
    Wiesner, RH
    Kamath, PS
    JOURNAL OF HEPATOLOGY, 2003, 38 : 73 - 73
  • [43] Model for end-stage liver disease score and MELD exceptions: 15 years later
    Sumeet K. Asrani
    Patrick S. Kamath
    Hepatology International, 2015, 9 : 346 - 354
  • [44] THE USE OF MELD SCORE (MODEL FOR END-STAGE LIVER DISEASE) AND DERIVATIVES IN CARDIAC TRANSPLANTATION
    Oliveira de Moraes, Ana Claudia
    Lucena da Fonseca-Neto, Olival Cirilo
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2018, 31 (02):
  • [45] Does model for end-stage liver disease (meld) score correlate with quality of life?
    Byrne, TJ
    Douglas, DD
    Vargas, HE
    Balan, VC
    Harrison, ME
    Moss, A
    Reddy, KS
    Rakela, J
    Mulligan, DC
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 219 - 219
  • [46] IMPACT OF THE MODEL OF END-STAGE LIVER DISEASE (MELD) IN THE NETHERLANDS: A SINGLE CENTRE EXPERIENCE
    Garritsen, R.
    Metselaar, H. J.
    de Man, R. A.
    Tilanus, H. W.
    Kazemier, G.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S159 - S159
  • [47] Hereditary hemorrhagic telangiectasia and symptomatic liver disease
    Boyce, DA
    Gordon, SC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S182 - S182
  • [48] Does the Model for END-Stage Liver Disease (MELD) Underestimate the Severity of Liver Disease in Women with Kidney Dysfunction?
    Mindikoglu, Ayse L.
    Magder, Laurence S.
    Kupin, Warren L.
    Regev, Arie
    GASTROENTEROLOGY, 2009, 136 (05) : A797 - A797
  • [49] Comparison of Mortality Prediction Between the Model for End-Stage Liver Disease-3.0 (MELD-3.0) and the Model for End-Stage Liver Disease-Lactate (MELD-La) in Korean Patients with Liver Cirrhosis
    Yoo, Seung-Kang
    Kim, Jeong-Han
    Choe, Won-Hyeok
    Kwon, So-Young
    MEDICINA-LITHUANIA, 2025, 61 (03):
  • [50] Center Variation in the Use of Nonstandardized Model for End-Stage Liver Disease Exception Points
    Goldberg, David S.
    Makar, George
    Bittermann, Therese
    French, Benjamin
    LIVER TRANSPLANTATION, 2013, 19 (12) : 1330 - 1342
12345